Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis

• Authors: MOTOVSKA Z.; JARKOVSKÝ Jiří; KOVARIK A.; MROZEK J.; HLINOMAZ Ota; PRECEK J.; HROMADKA M.; ZOHOR A.; KALA Petr; TOMASOV P.; CERVINKA P.; MATEJKA J.; BENEŠOVÁ Klára; DRABKOVA S.
• Year of publication: 2023
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Recommendations for the preference of prasugrel over ticagrelor just before PCI in NSTE ACS are based on limited and controversial evidence. Furthermore, prasugrel can’t be used in patients after a stroke/TIA, and the risk of bleeding in older and low-weight patients annuls its benefit. Purpose We aimed to add to the current evidence comparing the benefit of prasugrel and ticagrelor just before PCI (without pretreatment) in NSTE ACS patients.